Virostem Biotechnology is a biotechnology startup based in Turkey, founded in 2020. The company specializes in gene editing technologies and applications and has developed a range of CRISPR-based gene editing products. With a team of scientists boasting 15+ years of experience in both academic and industry settings, Virostem offers customized solutions and services for academic, clinical, and industrial researchers in the field of gene editing and gene therapy. The company prides itself on its optimized production pipeline, which allows it to offer gene editing products at competitive prices while maintaining the highest international quality standards.
Currently, there is no publicly available information regarding Virostem's last investment or the involved investors.
There is no investment information
No recent news or press coverage available for Virostem Biotechnology.